Skip to main content
RAPT Therapeutics, Inc. logo

RAPT Therapeutics, Inc. — Investor Relations & Filings

Ticker · RAPT ISIN · US75382E1091 LEI · 549300MB473BIU78ES48 US Manufacturing
Open in API
Filings indexed 534 across all filing types
Latest filing 2019-10-28 Capital/Financing Update
Country US United States of America
Listing US RAPT

About RAPT Therapeutics, Inc.

https://rapt.com/

RAPT Therapeutics, Inc. is a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for patients with inflammatory and immunologic diseases. The company's scientific approach involves developing therapeutics that intelligently target key drivers of the immune system. Its pipeline includes ozureprubart (RPT904), a long-acting anti-IgE antibody being evaluated in a Phase 2b clinical trial for the treatment of food allergies.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 4 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is an Amendment No. 4 to Form S-1 filed with the SEC, which is a registration statement for an initial public offering (IPO). It includes detailed information about the company, the offering, risk factors, management discussion, financial data, and other disclosures typical of an S-1 filing. This type of document is related to capital raising and securities registration, not a financial report, earnings release, or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPO registration statements.
2019-10-28 English
AMENDMENT NO. 3 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is titled 'Amendment No. 3 to Form S-1' and is a registration statement filed with the SEC under the Securities Act of 1933. It includes detailed information about the company's business, management, risk factors, use of proceeds, capitalization, and other disclosures typical of an S-1 registration statement for an initial public offering (IPO). The document is not a financial report like an annual or quarterly report, nor is it an earnings release or a management discussion. It is a regulatory filing related to capital raising and securities registration. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document length is substantial (15,000 characters), indicating it is the filing itself, not just an announcement. Confidence is high given the clear identification as an S-1 amendment filing for an IPO.
2019-10-22 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a correspondence letter addressed to the SEC regarding a Registration Statement on Form S-1, specifically confirming the withdrawal of a request for acceleration related to the Form S-1. It is a regulatory communication and does not contain financial data, report content, or detailed disclosures. The document length is short (1014 characters), and it is a letter rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory correspondence and filings that do not fit other categories.
2019-08-01 English
8A CERT
Regulatory Filings
2019-07-30 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter from underwriters to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It references the Securities Act of 1933 and Rule 461, which pertains to the registration process for securities offerings. The document is not a financial report, earnings release, or management discussion, but rather a procedural filing related to the registration and offering of securities. It is a regulatory communication about the timing of the registration statement becoming effective, not the registration statement itself or a financial report. The document length is short (3085 characters) and it is a formal request letter, fitting the category of a Regulatory Filing (RNS) rather than a report or announcement of a report.
2019-07-26 English
Regulatory Filings 2019
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-1. It is a correspondence related to a securities offering process, specifically a request for the SEC to declare the registration statement effective earlier. The document does not contain financial statements, management discussion, or detailed financial data. It is a regulatory communication related to capital raising but not a report or announcement of financial results. Given the nature of the document as a regulatory filing related to securities registration and acceleration request, it fits best under Regulatory Filings (RNS). The document length is short and it is not a report itself but a formal request letter.
2019-07-26 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.